scholarly journals Knee-High Devices Are Gold in Closing the Foot Ulcer Gap: A Review of Offloading Treatments to Heal Diabetic Foot Ulcers

Medicina ◽  
2021 ◽  
Vol 57 (9) ◽  
pp. 941
Author(s):  
Peter A. Lazzarini ◽  
Gustav Jarl
Keyword(s):  
Clinical Practice ◽  
Diabetic Foot ◽  
Gold Standard ◽  
Disease Burden ◽  
Foot Ulcers ◽  
Supporting Evidence ◽  
Diabetic Foot Ulcers ◽  
The Common ◽  
Common Barriers ◽  
Global Disease Burden

Diabetic foot ulcers (DFU) are a leading cause of the global disease burden. Most DFUs are caused, and prolonged, by high plantar tissue stress under the insensate foot of a person with peripheral neuropathy. Multiple different offloading treatments have been used to try to reduce high plantar tissue stress and heal DFUs, including bedrest, casting, offloading devices, footwear, and surgical procedures. The best offloading treatments are those that balance the benefits of maximizing reductions in high plantar tissue stress, whilst reducing the risks of poor satisfaction, high costs and potential adverse events outcomes. This review aimed to summarize the best available evidence on the effects of offloading treatments to heal people with DFUs, plus review their use in clinical practice, the common barriers and solutions to using these treatments, and discuss promising emerging solutions that may improve offloading treatments in future. Findings demonstrate that knee-high offloading devices, non-removable or removable knee-high devices worn for all weight-bearing activities, are the gold standard offloading treatments to heal most patients with DFU, as they are much more effective, and typically safer, quicker, and cheaper to use compared with other offloading treatments. The effectiveness of offloading treatments also seems to increase when increased offloading mechanical features are incorporated within treatments, including customized insoles, rocker-bottom soles, controlled ankle motion, and higher cast walls. However, in clinical practice these gold standard knee-high offloading devices have low rates of prescription by clinicians and low rates of acceptance or adherence by patients. The common barriers resulting in this low use seem to surround historical misperceptions that are mostly dispelled by contemporary evidence. Further, research is now urgently required to close the implementation gap between the high-quality of supporting evidence and the low use of knee-high devices in clinical practice to reduce the high global disease burden of DFU in future.

Technique for Fabrication of an “Instant Total-Contact Cast” for Treatment of Neuropathic Diabetic Foot Ulcers

2002 ◽  
Vol 92 (7) ◽  
pp. 405-408 ◽  
Author(s):  
David G. Armstrong ◽  
Brian Short ◽  
Eric H. Espensen ◽  
Patricia L. Abu-Rumman ◽  
Brent P. Nixon ◽  
...  
Keyword(s):  
Diabetic Foot ◽  
Gold Standard ◽  
Simple Technique ◽  
Patient Adherence ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Pressure Reduction ◽  
Critical Component ◽  
Total Contact Cast ◽  
Equivalent Time

Addressing pressure reduction in the treatment of diabetic foot wounds is a critical component of therapy. The total-contact cast has proven to be the gold standard of treatment because of its ability to reduce pressure and facilitate patient adherence to the off-loading regimen. Removable cast walkers have proven to be as effective as total-contact casts in pressure reduction, but this has not translated into equivalent time to healing. A simple technique to convert the removable cast walker into a device that is not as easily detached from the lower extremity, thereby encouraging the use of this device over a 24-hour period, is presented in this article. The procedure involves wrapping the cast walker with cohesive bandage or plaster of Paris. In the authors’ opinion, this technique addresses many of the disadvantages of the total-contact cast, resulting in an adequate compromise in this aspect of care. (J Am Podiatr Med Assoc 92(7): 405-408, 2002)

Leczenie miodem owrzodzeń cukrzycowych stóp

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Bogdan Kędzia ◽  
Elżbieta Hołderna-Kędzia
Keyword(s):  
Clinical Practice ◽  
Diabetic Foot ◽  
Clinical Studies ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Stages Of Development ◽  
Health Threat ◽  
Beneficial Effects ◽  
Neurogenic Origin

Diabetic foot ulcers are of neurogenic or angiogenic origin. In both cases they pose a serious health threat because their treatment is difficult and in many cases is ineffective. A serious complications in the treatment of this disease are caused by microorganism infections that are resistant to antibiotics. Hence the search for other effective healings of diabetic foot ulcers. One solution is to use bee honey for this purpose. The clinical studies presented in the work prove that the use of honey dressings in diabetic foot ulcers provide very beneficial effects, better and faster achievable than in the case of preparations generally used in clinical practice. For this reason, bee honey can be successfully applied in the treatment of diabetic foot ulcers, both of angiogenic and neurogenic origin, at different stages of development, including gangrenous processes.

The MABAL Shoe, an Alternative Method in Contact Casting for the Treatment of Neuropathic Diabetic Foot Ulcers

2000 ◽  
Vol 21 (4) ◽  
pp. 320-323 ◽  
Author(s):  
Rutger Jan Hissink ◽  
Hendrik Anton Manning ◽  
Jeff G. van Baal
Keyword(s):  
Surface Area ◽  
Diabetic Foot ◽  
Gold Standard ◽  
Healing Time ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Plantar Ulcers ◽  
The Mean ◽  
Total Contact Casting ◽  
Methods Of Treatment

INTRODUCTION: Total Contact Casting (TCC) is considered the gold standard in the treatment of neuropathic diabetic foot ulcers. To overcome some disadvantages of TCC we developed a removable fiberglass combicast shoe - the MABAL shoe. PATIENTS AND METHODS: The MABAL shoe was used to treat 23 plantar ulcers. RESULTS: Before treatment the mean surface area was 2.0 cm 2 (0.5–7.1 cm 2 ). Twenty-one of 23 ulcers healed, with a mean healing time of 34 days (7–75 days). CONCLUSION: The MABAL shoe provides healing of neuropathic diabetic foot ulcers comparable to existing methods of treatment, while offering some potential advantages. The main advantages are mobilization of the ankle, removability of the cast and a less time consuming form of treatment.

The Real-Life Outcome of VACOped Boot in the Management of Diabetic Foot Ulcers

2020 ◽  
pp. 153473462094267
Author(s):  
Wee Teck Lim ◽  
Helen Robinson ◽  
Edward Jude ◽  
Satyan Rajbhandari
Keyword(s):  
Clinical Trials ◽  
Confidence Interval ◽  
Median Duration ◽  
Diabetic Foot ◽  
Gold Standard ◽  
Standard Treatment ◽  
Real Life ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Total Contact Cast

The total contact cast (TCC) is considered the gold standard treatment to off-load diabetic foot ulcers (DFUs); however, the use of TCC can be limited due to various reasons such as underlying infections, ischemia, and patient’s reluctance. Removable cast walkers are used in such cases, and the VACOped boot is one such device. The aim of this study was to analyze the results of the VACOped boot in the treatment of DFUs in real life. Case records of all patients with DFUs treated with a VACOped from 2011 to 2017 were reviewed retrospectively. Eighty-three episodes of ulcerations in 42 subjects were identified, of which 48 (57.8%) healed in a median duration of 17.5 (95% confidence interval = 15-33) weeks with the use of the VACOped and 35 (42.2%) discontinued its use. The median duration of healing with the VACOped of 17.5 weeks appears to be longer, but this cohort included patients with underlying infection and ischemia, which are often excluded in the clinical trials of off-loading. Our data show that the VACOped application is preferred by many patients and seems to be equally effective to other removable cast walkers.

scholarly journals MON-626 Frequency and Associated Factors with Multidrug-Resistant Organism Infection in Diabetic Foot Ulcers in a Peruvian Public Hospital

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Marlon Augusto Yovera-Aldana ◽  
Liset Paola Sifuentes ◽  
Delia Cruz-Estacio ◽  
Diana Consuelo Flores ◽  
Lucy Nelly Damas-Casani
Keyword(s):  
Clinical Practice ◽  
Diabetic Foot ◽  
Associated Factors ◽  
Public Hospital ◽  
Multidrug Resistant ◽  
Foot Ulcers ◽  
Bivariate Analysis ◽  
Resistant Organism ◽  
Diabetic Foot Ulcers ◽  
International Expert

Abstract Objective: To determine the frequency and associated factors with multidrug-resistant organism (MDRO) infection among patients with diabetic foot ulcers in a Peruvian Public Hospital. Materials and methods. Cross-sectional survey was conducted from January 2017 -December 2018 at National Hospital in Lima Perú. Ulcers with clinical signs of infection (erythema, edema, pain, purulent exudate) according Infectious Diseases Society of America clinical practice guideline were included1. Wounds with only skin involvement were excluded. On admission, specimens for culture were obtained after cleansing and debriding of the wound. Samples were promptly sent to the microbiology laboratory for culture using appropriate transport media. Bacterial identification and antibiotic susceptibility testing were performed using the VITEK® 2 automated system (BioMérieux Laboratory, Argentina). Multidrug-resistant organisms were identified according to the recommendations of International Expert Proposal2. Prevalence ratios derived from bivariate analysis are given with their 95% CI, which was performed to study factors associated with the presence of multidrug-resistant bacteria; and a multivariate analysis with a lineal model to associated variables found in the bivariate analysis. This study has the approval of the Research Ethics Committee of the María Auxiliadora Hospital. Results Among 153 selected subjects, 75% were male, with an average age of 59 yo, 70% had ≥10 years of diabetes duration and only 16% had HbA1C <7%. A frequency of 85% of patients with MDRO infection was found and was associated with minor amputation RP 1.18 (95% CI 1.01-1.44) and with hospitalization time of ≥ 28 days RP 1.21 (95% CI 1.03-1.30). Conclusion. 6 of 7 patients have MDRO infection among patients with diabetic foot ulcers and are associated with the occurrence of minor amputation and hospitalization time ≥ 28 days. References 1. Lipsky BA, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73. 2. Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81.

Abstract #295 Epidemiologic and Clinical Characteristics of Diabetic Foot Ulcers – Report From South West Nigeria

2019 ◽  
Vol 25 ◽  
pp. 121-122
Author(s):  
Olufunmilayo Adeleye ◽  
Ejiofor Ugwu ◽  
Anthonia Ogbera ◽  
Akinola Dada ◽  
Ibrahim Gezawa ◽  
...  
Keyword(s):  
Diabetic Foot ◽  
Clinical Characteristics ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
South West
Sign in / Sign up

Export Citation Format

Share Document